Article Text

Download PDFPDF
Images
Zebra in the stomach
  1. Brian M Fung1,2,
  2. Adam J Gomez2,3,
  3. Rakesh Nanda1,2
  1. 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
  2. 2 Phoenix VA Health Care System, Phoenix, Arizona, USA
  3. 3 Department of Pathology, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA
  1. Correspondence to Dr Brian M Fung, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Arizona College of Medicine – Phoenix, Phoenix, Arizona, USA; brianfung{at}outlook.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A male in his 60s with stage five chronic kidney disease, hypertension, diabetes mellitus, hyperlipidemia, hypothyroidism and Barrett’s oesophagus presented to the endoscopy suite for Barrett’s oesophagus surveillance. His medications included aspirin, atorvastatin, ferrous sulfate, furosemide, glipizide, hydralazine, isosorbide mononitrate, levothyroxine, metoprolol succinate and sodium bicarbonate. He reported a history of tobacco and alcohol use. Physical examination was unremarkable. On oesophagogastroduodenoscopy, short-segment Barrett’s oesophagus was noted. In addition, stripes of dark pigment were seen in the antrum of the stomach (figure …

View Full Text

Footnotes

  • Correction notice This article has been corrected since it published Online First. The twitter statement has been removed.

  • Contributors BMF drafted the manuscript and prepared the figures. AJG assisted in acquiring images and critically reviewed the manuscript. RN critically reviewed the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.